NEONATAL TREATMENT WITH METHYLAZOXYMETHANOL ACETATE (MAM) AS A NEURODEVELOPMENTAL MODEL OF SCHIZOPHRENIA: BEHAVIORAL, PHARMACOLOGICAL AND MORPHOLOGICAL CHARACTERIZATION